SEC Form 4 · accession 0001524858-16-000009
Marker Therapeutics, Inc. · MRKR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joshua Silverman
Director
Period of report
Nov 28, 2016
Accepted (ET)
Nov 30, 2016 · 4:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001094038
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $4.82 | Nov 28, 2016 | A | 12,500 | A | — | Nov 27, 2026 | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1Represents options granted in connection with appointment as a director of the Company on November 28, 2016 under the Company's 2014 Omnibus Stock Ownership Plan. These shares shall vest in monthly installments over a two year period. The option exercise price is the closing price on the date of the grant, November 28, 2016.